UPDATE : Monday, September 7, 2020
상단여백
UBcare wins patent for tech to monitor suspected infectious diseases by Shim Hyun-tai 2020-09-04 18:04
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia by Shim Hyun-tai 2020-09-03 12:36
Recovered Covid-19 patients suffer from aftereffects – for long by Shim Hyun-tai 2020-09-02 20:12
Nation struggles to secure beds, workforce for severe Covid-19 patients by Shim Hyun-tai 2020-09-02 16:15
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries by Shim Hyun-tai 2020-09-02 14:08
라인
Korea approved 22 clinical studies for Covid-19 vaccines, treatments by Shim Hyun-tai 2020-09-01 18:02
MedPacto’s oncology pipeline for blood cancer wins EU patent by Shim Hyun-tai 2020-09-01 17:14
MSD’s antiviral Prevymis gains insurance coverage by Shim Hyun-tai 2020-09-01 15:05
T&R Biofab gains sales rights of pluripotent stem cell-derived cardiomyocyte by Shim Hyun-tai 2020-09-01 14:13
MSD Korea’s Keytruda wins 2 new indications for treating cancer by Shim Hyun-tai 2020-08-31 16:44
라인
China gives nod to Huonland’s eye drop for allergic inflammation by Shim Hyun-tai 2020-08-31 15:28
SNUH to introduce Toshiba’s heavy ion radiotherapy device by Shim Hyun-tai 2020-08-31 14:02
‘AI MRI model can diagnose autism’s severity, prognosis’ by Shim Hyun-tai 2020-08-28 18:04
Regulator names 2 more innovative medical devices by Shim Hyun-tai 2020-08-28 18:03
Takeda’s Alunbrig available as primary therapy for lung cancer by Shim Hyun-tai 2020-08-28 15:52
라인
Capital area tops Daegu as Covid-19 epicenter by Shim Hyun-tai 2020-08-28 14:54
‘Thyroid surgery using oral endoscopy reduces swallowing difficulties’ by Shim Hyun-tai 2020-08-27 18:06
SNUH opens new Covid-19 treatment center in 2 days by Shim Hyun-tai 2020-08-27 18:06
Genexine's cytokine drug effective on severe Covid-19 patients by Shim Hyun-tai 2020-08-27 18:05
New virus cases reach six-month high; tightest restrictions imminent by Shim Hyun-tai 2020-08-27 13:24
여백
여백
여백
Back to Top